This book will help the reader to understand fully the role of nuclear medicine in managing thyroid cancer patient; follow the latest evidence-based recommendations and guidelines wherever possible; assess the promising uses of recombinant human thyrotropin; refer patients to Phase 1-3 clinical trials; and discover new isotopic imaging techniques, such as PET and CT scanning.